This MN variability and higher levels of MN in esco2 heterozygous animals spurred a hypothesis that animals with higher proportion of cells with MN, would have more frequent p53 LOH events in precancerous somatic cells, therefore a larger pool of cells that could become tumor-forming, which would translate into earlier tumor onset (Fig 5B). This evidence concerns the gene TP53 and neoplasm.